Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
Iron is an essential element in the metabolism of all cells. Elevated levels of the metal have been found in the brains of patients of numerous neurodegenerative disorders, including Parkinson's disease (PD). The pathogenesis of PD is largely unknown, although it is thought through studies with...
Saved in:
| Main Authors: | Ross B. Mounsey, Peter Teismann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | International Journal of Cell Biology |
| Online Access: | http://dx.doi.org/10.1155/2012/983245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
by: Ross B. Mounsey, et al.
Published: (2011-01-01) -
Nigrostriatal iron accumulation in the progression of Parkinson’s disease
by: M. López-Aguirre, et al.
Published: (2025-04-01) -
Sex and Gender Differences in Iron Chelation
by: Sarah Allegra, et al.
Published: (2024-12-01) -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
by: Emanuele Angelucci, et al.
Published: (2017-03-01) -
IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01)